Source: Harvest One
  • Harvest One Cannabis (HVT) has signed a supply agreement with Canopy Growth Corporation
  • The agreement enables Harvest One to sell its LivRelief Infused topical creams on Canopy’s Spectrum Therapeutics’ online medical store
  • Under the agreement, Valens will supply Spectrum Therapeutics with Harvest One’s licensed LivRelief Infused products
  • Spectrum Therapeutics offers its patients medical cannabis products from Canopy Growth brands and select partner brands
  • Harvest One is a global cannabis-infused and non-infused CPG company
  • Shares of Harvest One Cannabis Inc. opened trading at $0.04

Harvest One Cannabis (HVT) has signed a supply agreement with Canopy Growth Corporation.

The agreement enables Harvest One to sell its LivRelief Infused topical creams on Canopy’s Spectrum Therapeutics’ online medical store via an extension of its licensing agreement with Valens Agritech Ltd, a wholly-owned subsidiary of The Valens Company.

LivRelief Infused topical creams will be the first Harvest One product sold at the Spectrum Therapeutics store, marking a new distribution milestone for the company.

Under the agreement, Valens will supply Spectrum Therapeutics with Harvest One’s licensed LivRelief Infused products to make them available to patients through Spectrum Therapeutics’ online medical store.

Spectrum Therapeutics offers its patients medical cannabis products from Canopy Growth brands and select partner brands.

“We are very pleased to work with Canopy Growth via our licensing agreement with Valens to distribute Harvest One’s LivRelief Infused brand of topical creams in Spectrum Therapeutics’ online store,” said Gord Davey, President and Chief Executive Officer of Harvest One.

“This is an amazing opportunity for our teams to work together to bring these top-selling infused pain topical creams to more patients,” he added.

“We are dedicated to offering Spectrum Therapeutics patients the widest range of high-quality cannabis products and formats available both from Canopy Growth brands and through agreements with select partner brands like Harvest One,” said Grant Caton, General Manager, Canada, at Canopy.

Harvest One is a global cannabis-infused and non-infused CPG leader that develops and distributes premium health, wellness and self-care products with a market focus on solutions for sleeplessness and pain, resulting in the reduction of fatigue and anxiety.

Shares of Harvest One Cannabis Inc. opened trading at $0.04.

More From The Market Online

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.

The Market Online’s Weekly Cannabis Report – May 10, 2024

A leading North American cannabis and consumer packaged goods company will acquire key players in its U.S. expansion strategy.

Canopy Growth prepares for U.S. expansion with new acquisitions

Canopy Growth (TSX:WEED) exercises its options to acquire Wana and Jetty Extracts, key players in the company's U.S. expansion strategy.